The Common Technical Document(CTD) is part of the ICH(International Conference on Harmonization) program for developing global, harmonized guidelines for the contents and format of new drug and biologic products applications to be submitted to regulatory agencies in the ICH regions. The CTD is divided into 5 modules : 1. Region specific administrative and prescribing information 2. High level summary 3. Quality -chemical, pharmaceutical and biological documentation 4. Non-clinical study reports 5. Clinical study reports. The potential advantages of CTD can be extensive. A pharmaceutical companies could save in resources and time, so that they could facilitate simultaneous submissions in ICH regions. Also, CTD could provide a more efficient evaluation process with regulators, as well. Finally, a faster availability of new medicines is expected in the future. The CTD was first agreed upon in 2000 and now required in the EU, Japan, Canada and Switzerland and is strongly encouraged in the US. In Korea, CTD submissions will be accepted by KFDA for New Drug Application in March, 2009. In this session, a general overview of the CTD documents and a detailed introduction with each modules will be presented. The background, scientific and regulatory aspects of CTD documents will be focused.
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동